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PERSPECTIVES IN BASIC SCIENCE
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Renal basement membrane components. Basement mem- for the glomerular basement membrane (GBM), a thick-
branes are specialized extracellular matrices found throughout ened basement membrane composed of specialized base-
the body. They surround all epithelia, endothelia, peripheral ment membrane protein isoforms that are critical for itsnerves, muscle cells, and fat cells. They play particularly impor-
filtration function and for maintaining its structure.tant roles in the kidney, as demonstrated by the fact that defects
in renal basement membranes are associated with kidney mal- In this review, I describe the major basement mem-
function. The major components of all basement membranes brane components and discuss their localization in the
are laminin, collagen IV, entactin/nidogen, and sulfated proteo- kidney (and elsewhere, when appropriate) at maturityglycans. Each of these describes a family of related proteins
and during development and their involvement in renalthat assemble with each other in the extracellular space to
disease. In Figure 1, a schematic summary of the distribu-form the basement membrane. Over the last few years, new
basement membrane components that are expressed in the tion pattern of the major basement membrane compo-
kidney have been discovered. Here, the major components and nents in various segments of the nephron and in the
their localization in mature and developing renal basement
collecting duct has been provided. For more detailedmembranes are described. In addition, the phenotypes of base-
analyses of basement membrane assembly, structure, andment membrane component gene mutations, both naturally
occurring and experimental, are discussed, as is the aberrant function, readers should consult both classic and more
deposition of basement membrane proteins in the extracellular up-to-date overviews [1–5]. Here, special attention is
matrix in several renal diseases. paid to how mutations in basement membrane protein
genes have provided valuable insights regarding the
functions of their products in the kidney.
The entire outer surface of each individual nephron
and collecting duct is coated by a basement membrane,
a thin sheet of extracellular matrix composed primarily LAMININ
of laminin, collagen IV, entactin/nidogen, and sulfated What is known about laminin has increased drastically
proteoglycans. Basement membranes are thought to play
over the last 10 years, as various investigators working
roles in filtration, cell adhesion, migration, and differenti-
in different systems on their “own” proteins of interestation. It has become clear over the last decade, with
found themselves thrust into the laminin field upon mo-the identification and characterization of novel basement
lecular cloning and sequencing of the correspondingmembrane components, that all basement membranes
genes. Because of the resulting expansion of the lamininare not alike. This fact has especially important implica-
family, those researchers actively investigating lamininstions for understanding the biology of the kidney. Renal
(as well as those who merely wish to understand them)epithelial basement membranes exhibit a defined molec-
have had to endure not just one, but two changes inular heterogeneity, which corresponds in many ways to
nomenclature, and a third has been proposed. Some re-the segmental nature of the nephron. It is thought that
cent reviews provide excellent discussions of the struc-this molecular heterogeneity in the basement membrane
ture and function of laminins [6–10].may contribute to the functional specificity manifested
Laminin now refers to a still growing family of a, b,by distinct nephron segments. This is most certainly true
and g chains which form abg cruciform or Y-shaped
heterotrimers. Originally, laminin was thought to consist
Key words: extracellular matrix, kidney disease, laminin, collagen, en-
of a single trimer containing chains referred to as A, B1,tactin, glomerular basement membrane, tubular basement membrane.
and B2 [11]. These chains are now called a1, b1, and
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Fig. 1. Schematic drawing of a nephron and
an associated collecting duct, with the compo-
nents of the various basement membranes and
of the mesangial matrix listed. Components
in brackets were not observed in all species
tested, and those in lower case or small font
were observed only at low levels. As discussed
in the text, laminin trimers are predicted based
on immunohistochemical colocalization and
thus could be incorrect. However, they still
correctly describe which individual chains are
present. Abbreviations are: Lam, laminin; Col,
collagen; A, agrin; P, perlecan; B, bamacan;
GBM, glomerular basement membrane; MM,
mesangial matrix; BC, Bowman’s capsule; PT,
proximal tubule; LH, loop of Henle; DT, distal
tubule; CD, collecting duct.
ture regarding the biochemistry of laminin and its effects as any kind of proof that the chains are actually coassem-
bled to form the predicted trimers. Biochemical isolationon cells in culture deals with studies of laminin-1.
All laminin chains are evolutionarily related to each of pure trimers and identification of the constituent chains
are the recognized and respected methods. However, fewother, but they can be easily divided into a, b, and g
subfamilies based on sequence and domain arrangement pure laminin trimers have actually been isolated from kid-
ney, although there are some notable exceptions [20]. In[8]. In the current laminin nomenclature, laminin hetero-
trimers are named with Arabic numerals in essentially any event, the successful isolation and purification of a
laminin trimer from a tissue with basement membranes astheir order of discovery [12]. There are currently 12
reported heterotrimers assembled from five a, three b, heterogeneous as those found in the kidney will not reveal
anything about that trimer’s exact origin, so some predic-and three g chains (Table 1).
Most laminin chains are found in the kidney, as deter- tions will still have to be made. Therefore, for the sake of
simplicity, laminin trimers are referred to rather than tomined by immunohistochemical assays. It is formally possi-
ble to predict which laminin trimers are present in specific specific chains in cases in which trimer composition can be
reasonably inferred from immunohistochemical colocaliza-basement membranes by colocalizing a, b, and g chains
immunohistochemically, but this is not currently viewed tion studies, with the caveat that these predictions may be
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Table 1. Laminin trimer subunit composition genes causes Herlitz’s junctional epidermolysis bullosa,
a severe skin-blistering disease [35–39], but significantTrimer Subunits Reference
renal abnormalities associated with these mutations haveLaminin-1 a1b1g1 [13]
Laminin-2 a2b1g1 [14] not been reported.
Laminin-3 a1b2g1 Laminins-8 and -9 are essentially absent from adult
Laminin-4 a2b2g1 [14]
kidney, but they could play a role in nephrogenesis.Laminin-5 a3b3g2 [15]
Laminin-6 a3b1g1 [16] Laminin-8 is evident in the nascent epithelial basement
Laminin-7 a3b2g1 [17] membrane of the renal vesicle shortly after the mesen-
Laminin-8 a4b1g1 [18]
chyme to epithelium transition. Laminin-9 appears to beLaminin-9 a4b2g1 [18]
Laminin-10 a5b1g1 [14, 18] present in the immature GBM, but the a4 chain gradually
Laminin-11 a5b2g1 [14, 18] disappears as the glomerulus matures [18, 29].
Laminin-12 a2b1g3 [19]
Laminin-10 is likely the most abundant laminin trimer
in the mature kidney. It is found throughout the length
of all tubular and collecting duct basement membranes
[18, 22]. Laminin-11, on the other hand, is highly re-
incorrect. However, they still describe which individual
stricted in the kidney; it is found in only the GBM and
chains are present in particular basement membranes.
arteriolar (endothelial and vascular smooth muscle) base-
Despite its ease of isolation, widespread use, and long ment membranes. Laminin-11 is also the only trimer that
history, laminin-1 is somewhat rare overall in basement has been shown to be important for proper renal func-
membranes in vivo. However, the kidney is special in that tion. This was demonstrated by targeted mutation of the
it is a major site of laminin-1 accumulation at all stages laminin b2 chain gene. Mice lacking b2 exhibit massive
of development. In adult kidney, laminin-1 is found in proteinuria beginning at approximately seven days of
proximal tubular basement membranes (TBMs) in the age and die at three to five weeks of age. Ultrastructur-
cortex and in loops of Henle basement membranes in ally, the GBM appears normal, but the podocyte foot
the medulla [21, 22]. In nephron development, laminin-1 processes are fused. At the molecular level, the laminin
is thought to play an important role because antibodies
b1 chain substitutes for b2 in the basement membrane,
to the a1 chain inhibit the mesenchyme to epithelium but b1 is apparently functionally inadequate [40].
transition that occurs at the onset of nephrogenesis [23]. It is important to note here that based on in situ hybrid-
Laminin-2 is found in a subset of TBMs at low levels ization studies, the existence of laminin-11 in the GBM
[18, 22]. In mice and humans, it is also found in the has been questioned. This is because a5 and b2 RNAs
mesangial matrix, although in rat, this matrix contains were not detected inside the same cells [30], and laminin
laminin-4 instead [18, 22, 24, 25]. It is unclear what role trimers assemble inside cells. However, no laminin chains
(if any) laminins-2 and -4 might have in the kidney, as other than a5, b2, and g1 have been detected in the
mutations in the a2 chain, which cause muscular dystro- mature GBM [18, 21, 22, 24, 25, 41]. The existence of
phy in humans and mice [26–28], do not appear to cause as yet unreported a and b chains in the GBM or the
any renal defects. biochemical isolation of laminin-11 from glomeruli could
Laminin-3 is not apparent in the kidney, except perhaps resolve this important issue.
very transiently in the GBM during development [29]. We have generated mice with a targeted mutation in
However, its very existence has been questioned [30], the laminin a5 chain gene, and these mice therefore lack
and the only biochemical studies historically viewed as both laminins-10 and -11. The mutants die in utero at
identifying laminin-3 used monoclonal antibodies thought embryonic day 14 to embryonic day 17 and show defects
to recognize a1 [14], but which actually recognize a5 [31]. in neural tube closure, digit septation, and maturation
Deposition of laminins-5, -6, and -7 (the a3-containing of the placenta [42]. We are still in the midst of character-
laminins) has not been examined in great detail in the izing internal organ defects, some of which are quite
kidney, so it is difficult to make predictions about which subtle, but it is evident that some embryos have small
of these trimers are present. In addition, there are some or absent kidneys, suggesting an important role for the
conflicting results in the literature. In adult kidney, we laminin a5 chain in kidney development (J.H.M., manu-
found a3 to be associated with the basement membrane script in preparation).
underlying the epithelium of the renal papilla, but it was The existence of laminin-12 was only recently reported
not detectable in glomerular, tubular, or collecting duct [19]. Laminin-12 contains the novel g3 chain. Although
basement membranes [18]. Although we detected little g3 has been shown to be expressed in the kidney by
a3 in developing kidney, others reported the presence Northern blot analysis and by in situ hybridization [19,
of a3 in ureteric buds [32]. In addition, laminin g2 was 43], it has not yet been localized to specific basement
found in collecting duct as well as in proximal and distal membranes or elsewhere in the kidney by immunohisto-
chemical methods.TBMs [33, 34]. Mutation in any of the laminin-5 subunit
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COLLAGEN IV 65] and an analogous disease in dogs and knockout mice
[66–68]. It has also been shown that a point mutation inCollagen IV, like laminin, is a ubiquitous component
the a4 chain gene is responsible for autosomal dominantof basement membranes. The collagen IV network, which
benign familial hematuria (also known as thin GBMis proposed to have a structure similar to chicken wire,
disease) [69], and autosomal dominant Alport syndromeis composed of approximately 180 kDa a chains. There
has been linked to the juxtaposed a3 and a4 chain genesare six genetically distinct a chains (a1 through a6),
[70]. These findings are extremely important becauseand all have similar domain structures: There is a short
they show that mutations in type IV collagen chain genesnoncollagenous NH2-terminal domain called 7S, a long
can be responsible for the full spectrum of Alport syn-central collagenous domain composed of interrupted
drome-like GBM abnormalities and the observed modesGly-X-Y amino acid triplet repeats, and a COOH-termi-
of inheritance.nal noncollagenous domain called NC1. a chains assem-
A particularly interesting aspect of Alport syndromeble to form triple helical rod-like trimers, and these tri-
is that in most cases, the a3 through a5(IV) chains aremers organize into a network via 7S:7S and NC1:NC1
all absent from the GBM, despite the fact that only onetrimer:trimer interactions. Timpl, Paulsson, Hudson et
of the three chain genes harbors a mutation. However,al, Kuhn, and Pihlajaniemi further discuss this structure
this is perfectly consistent with the hypothesis that these
[1, 2, 44–47].
chains are all part of the same collagen IV network in
The a1 and a2 collagen IV chains assemble in a 2:1 the GBM and that this network requires all three chains
ratio to form the most widely deposited collagen IV for proper assembly [45, 60, 71]. Alternatively, Thorner
network, and, like laminin-1, these chains are a major et al found that a mutation of the a5 chain gene in dog
part of the EHS tumor extracellular matrix [48]. a1 and resulted in a reduction in mRNA levels for a3 and a4,
a2(IV) are essentially ubiquitous in basement mem- suggesting a transcriptional mechanism to explain their
branes, with the notable exceptions of the synaptic base- absence [72]. However, such a mechanism does not seem
ment membrane at the neuromuscular junction and, at applicable in the mouse and human diseases, where post-
least in rodents, the GBM. These very specialized base- transcriptional mechanisms seem more likely [67, 68, 73].
ment membranes instead contain the a3 through a5(IV) In the absence of the a3 through a5(IV) chains, the
chains [24, 25, 49–52]. [a6(IV) deposition has not yet a1 and a2(IV) chains substitute to form the GBM [59,
been assessed at synapses, but it is absent from the 66–68, 72, 74–76]. This basement membrane appears nor-
GBM.] Exactly how the a3 through a6(IV) chains assem- mal early in life but becomes damaged over time, and
ble stoichiometrically into a trimer has been difficult to this correlates with the delayed onset, progressive nature
ascertain. However, it is clear that there are networks of Alport syndrome. In an attempt to identify potential
in basement membranes that contain a3 through a6(IV) mechanisms for this damage, it was shown that bulk
that are separate from the a1/a2(IV) network [53–55]. collagen IV isolated from human Alport kidney [con-
As far as the nephron is concerned, the pattern of taining primarily a1 and a2(IV) chains] was more suscep-
tible to endoproteolysis than a similar isolate from nor-collagen IV chain deposition varies somewhat from spe-
mal kidney [containing a1 through a6(IV)], suggestingcies to species. In human GBM, the a3 through a5(IV)
that Alport GBM is slowly damaged by endogenous pro-chains predominate, but lower levels of a1 and a2(IV)
teases that have little effect on normal GBM [77].are present and have been localized by immunoelectron
The collagen a3(IV) chain is also of keen interestmicroscopy to the subendothelial aspect of the GBM [56].
because it harbors the auto-antigen associated with Good-In rodents, little if any a1 and a2(IV) can be detected
pasture syndrome, an autoimmune disorder consistingin the GBM [25], but they are part of the mesangial
of glomerulonephritis, pulmonary hemorrhage, and anti-matrix in all species tested. A perhaps more significant
GBM antibody formation [44]. The Goodpasture antigendifference among species is that in the tubular portion
is contained in the NC1 domain of a3 [78–82]. In aof the nephron, the a3 through a6(IV) chains are con-
phenomenon related to Goodpasture syndrome, a mi-fined to distal TBMs in humans, but a3 through a5(IV)
nority of Alport patients with a renal transplant developare present additionally in proximal TBMs in rodents
the renal manifestations of Goodpasture syndrome inand cow. Along with these chains, a1 and a2(IV) are
the allograft. This has been shown to result from thefound ubiquitously in TBMs. In Bowman’s capsular base-
production of alloantibodies to the NC1 domain of the
ment membrane, the major chains are a1, a2, a5, and
a3 and/or the a5(IV) chains that are present in the trans-
a6(IV) [25, 57–59]. planted kidney but not in the native kidneys [51, 83–87].
The importance of the a3 through a5(IV) chains to
the proper function of the GBM is underscored by the
ENTACTIN/NIDOGENeffects of mutations in the genes that encode these chains
[60–62]. The most severe mutations cause Alport syn- The component referred to both as entactin and nido-
gen (En/Nd) is an elongated approximately 150 kDadrome (hereditary glomerulonephritis) in humans [63–
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molecule containing three globular domains separated tion. These functions might not have been revealed in
studies of this agrin mutant because the mutation onlyby two linear segments. It serves as a link between the
laminin and collagen IV networks in all basement mem- affects a portion of the protein, and a form of agrin still
accumulates in basement membranes [101]. However,branes [1, 4, 88]. En/Nd binds tightly to laminin via the
laminin g1 chain short arm [89] and also binds to collagen ongoing studies of new knockout mice with a null muta-
tion in the agrin gene have not revealed any obviousIV; it does not bind well to laminin-5, which contains the
g2 chain [90]. Recently, homologues of En/Nd have been defects in the kidney, but because the mice die at birth,
renal function in the absence of agrin cannot be rigor-identified in both mouse and human, and these are called
entactin-2 [91] and nidogen-2 [92], respectively. These ously addressed (R.W. Burgess and J.R. Sanes, personal
communication).molecules are apparently orthologous and exhibit a wide
pattern of expression quite similar to that of En/Nd. How- Bamacan (basement membrane chondroitin sulfate
proteoglycan) exhibits a wide distribution in basementever, antibodies to nidogen-2 show that although it is
ubiquitous in renal basement membranes (like En/Nd), membranes [102], and in the kidney, bamacan is detected
in the mesangial matrix and in virtually all basementit has a more restricted distribution pattern in skeletal
and cardiac muscle [92]. In terms of the kidney, it remains membranes except the GBM [103]. Interestingly, bama-
can is a component of the GBM during kidney develop-to be determined whether these molecules have specific
functions there or whether they have general roles in for- ment, but it is gradually eliminated by maturity [104].
Thus, it may play some as yet unknown role in glomerulo-mation and/or maintenance of all basement membranes.
genesis.
Collagen XVIII, which has recently been shown to be
BASEMENT MEMBRANE PROTEOGLYCANS
a HSPG, is a widely deposited component of basement
Proteoglycans, which are found in all basement mem- membranes, including those found associated with renal
branes, consist of protein cores with attached heparan tubules and glomeruli (abstract; Naito et al, J Am Soc
sulfate, chondroitin sulfate, and/or dermatan sulfate side Nephrol 19:523A, 1998) [105, 106]. Although the func-
chains [93, 94]. These long carbohydrate chains impart tion of collagen XVIII in basement membranes is un-
a negative charge to the molecule and contribute to the known, it will certainly be the subject of intense atten-
negative charge of basement membranes. This is thought tion, as the C-terminal fragment of the a1(XVIII) chain
to be especially important to the charge-selective ultra- is endostatin, an angiogenesis inhibitor that can induce
filtration properties of the GBM [95], so proteoglycans tumor regression [107].
have historically been of significant interest in terms of
their pattern of deposition in the kidney. In addition,
DEVELOPMENTAL TRANSITIONSproteoglycans are thought to stabilize the basement
membrane by binding laminin, collagen IV, and En/Nd. Basement membrane dynamics are an important as-
pect of kidney development. A recent review detailed theBecause it is a component of the EHS tumor matrix,
perlecan is the best studied heparan sulfate proteoglycan transitions in basement membrane component deposition
that occur during kidney development [29], so only a lim-(HSPG) and was once considered essentially ubiquitous
in basement membranes [93, 96]. However, recent stud- ited discussion of transitions in collagen IV and laminin
chains are presented here. Kidney development involvesies have identified novel proteoglycans that supplement
and/or replace perlecan in some basement membranes. mesenchyme to epithelium transformations and complex
morphological changes [108, 109]. Coincident with theseFor example, agrin is a HSPG [97] that is present through-
out the width of the mature GBM, whereas perlecan is morphological changes are molecular transitions in the
basement membrane components that are found in vari-restricted to the subendothelial aspect of the GBM [40,
98, 99]. Perlecan is ubiquitous in the other renal base- ous parts of the developing nephron. This is most dramat-
ically demonstrated by changes in the composition ofment membranes, whereas lower levels of agrin are de-
tected in some TBMs [100]. the developing GBM, in terms of the laminin and type
IV collagen isoforms that are deposited there. For exam-Based on studies of mice with a targeted mutation in
agrin, the only known function of agrin is to signal the ple, at the S-shaped stage of nephrogenesis, the future
GBM contains the a1 and a2 chains of collagen IV andclustering of preexisting acetylcholine receptors on the
surface of muscle fibers. Agrin mutant mice die at or laminins-1, -8, and -10. At the capillary loop stage, the
laminin b2 chain appears, probably as a constituent ofshortly before birth because of paralysis caused by the
absence of any significant neuromuscular transmission laminin-11, and the collagen a3 through a5(IV) chains
are deposited and are thought to form a network sepa-[101]. No other abnormalities have been detected. Given
its signaling and general physical properties, agrin might rate from the one composed of the a1 and a2(IV) chains.
As the glomerulus matures, the a1/a2(IV) network isalso have a role in kidney development, in basement
membrane structural integrity, or in glomerular filtra- diminished and becomes confined to the subendothelial
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aspect of the GBM in humans and is virtually eliminated concentration may induce expression of transforming
in rodents and dog. Laminin-11 continues to be deposited growth factor-b, which, in turn, induces extracellular ma-
into the GBM, and the other laminins are gradually trix gene expression and an increase in matrix deposition.
eliminated by an unknown mechanism [18, 22, 25, 52, Alternatively, the high glucose may cause glycation of
77, 110–112]. matrix proteins, which, in turn, decreases their turnover.
As discussed earlier in this article, in Alport syndrome, In addition to the observed increases, glomerular HSPG
mutations in one of the COL4A3-COL4A5 chain genes levels have been shown to be reduced in diabetic ne-
prevents accumulation of all three of these chains. As a phropathy, and this may contribute to proteinuria by
consequence, the collagen IV chain transition cannot affecting the charge-selective barrier of the GBM.
occur in the GBM, and this leads to a retention of the In a different glomerulopathy, membranous nephrop-
a1 and a2(IV) chains throughout the width of the GBM. athy, the GBM “spikes” stained with antibodies to the
Although these chains function properly early in life, collagen a3 through a5(IV) chains, entactin/nidogen, lam-
they eventually fail to maintain the proper structure and inin, and HSPG [117, 118]. In the interstitium of patients
function of the GBM, leading to the delayed-onset glo- with chronic renal disease, abnormal deposition of colla-
merulonephritis characteristic of Alport syndrome. Like- gens IV, V, and VI, laminin, and HSPG was observed,
wise, the laminin transitions that occur in the developing and the extent of their deposition correlated with the
GBM have been experimentally prevented by mutating severity of the histologic lesions [119]. Finally, the lami-
the laminin b2 chain gene in mice [40, 113]. Because nin b2 and collagen a3(IV) chains were found to be
the b1 to b2 transition cannot occur, these mice retain aberrantly deposited in proximal TBMs of transplanted
functionally inadequate b1-containing laminins in their kidneys undergoing chronic rejection. Importantly, allo-
GBMs. Although these GBMs appear ultrastructurally grafts exhibiting pathology characteristic of cyclosporine
normal, they do not function properly [40]. These results toxicity did not have such deposits. This suggests that the
show that laminin b2 has an important role in the GBM fibroses observed in chronic rejection and cyclosporine
that cannot be compensated for by the related b1 chain. toxicity have different underlying mechanisms [120].
BASEMENT MEMBRANE COMPONENTS CONCLUSIONS
AND DISEASE
Basement membranes are of undisputed importance
Abnormal deposition of basement membrane and to the function of the kidney. Their diverse constituent
other extracellular matrix components has been ob-
proteins not only contribute to their formation and func-
served in several disease states that, in contrast to Alport
tion, but some components have also been shown to be
syndrome, do not involve defects in genes encoding ma-
involved in glomerular and tubulointerstitial diseases,trix components. In these cases, the matrix abnormalities
either because of mutation or increased deposition inare secondary to an underlying pathophysiology that
the extracellular matrix. With the impending completionmay or may not be well understood. An extensive discus-
of the sequencing of the human genome, new basementsion of this complex topic is beyond the scope of this
membrane components will likely be identified. A morereview, but a few examples of abnormal matrix accumu-
complete understanding of the biology of all basementlation in renal disease are worth mentioning. Further-
membrane components will hopefully lead to better toolsmore, given the recent discoveries of novel basement
and improved approaches for investigating the causes ofmembrane components, it is important that they also be
renal disease and its progression and for preventing orassayed for abnormal deposition in the diverse array of
attenuating the progressive nature of renal disease.human kidney diseases.
One prominent example is the aberrant accumulation Reprint requests to Jeffrey H. Miner, Ph.D., Renal Division Box
8126, Washington University School of Medicine, 660 South Euclidof matrix molecules in diabetic nephropathy [114–116].
Avenue, St. Louis, Missouri 63110, USA.Thickening of the GBM and expansion of the mesangial
E-mail: minerj@thalamus.wustl.edumatrix characterize the diffuse glomerulosclerosis associ-
ated with the onset of albuminuria in insulin-dependent
REFERENCESdiabetics. It has been shown that the collagen a3 through
1. Timpl R: Structure and biological activity of basement membranea5(IV) chains, collagen V, laminin, fibronectin, and se-
proteins. Eur J Biochem 180:487–502, 1989rum proteins contribute to the thickened GBM, whereas
2. Paulsson M: Basement membrane proteins: Structure, assembly,
the collagen a1, a2(IV) chains, collagens V and VI, lami- and cellular interactions. Crit Rev Biochem Mol Biol 27:93–127,
1992nin, and fibronectin comprise the expanded mesangium.
3. Yurchenco PD, O’Rear JJ: Basal lamina assembly. Curr OpinSeveral mechanisms for the accumulation of these pro-
Cell Biol 6:674–681, 1994
teins that take into account the hyperglycemia associated 4. Timpl R: Macromolecular organization of basement membranes.
Curr Opin Cell Biol 8:618–624, 1996with diabetes have been proposed. The high glucose
Miner: Renal basement membrane components2022
5. Timpl R, Brown JC: Supramolecular assembly of basement mem- son F, Weissenbach J, Tome FM, Schwartz K, Fardeau M,
branes. Bioessays 18:123–132, 1996 Tryggvason K: Mutations in the laminin alpha 2-chain gene
6. Timpl R, Brown JC: The laminins. Matrix Biol 14:275–281, 1994 (LAMA2) cause merosin-deficient congenital muscular dystro-
7. Delwel GO, Sonnenberg A: Laminin isoforms and their integrin phy. Nat Genet 11:216–218, 1995
receptors, in Adhesion Receptors as Therapeutic Targets, edited 28. Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima
by Horton MA, Boca Raton, CRC Press, Inc., 1996, pp 9–36 Y, Arahata K, Takeda S: Laminin alpha2 chain-null mutant
8. Engvall E, Wewer UM: Domains of laminin. J Cell Biochem mice by targeted disruption of the Lama2 gene: A new model
61:493–501, 1996 of merosin (laminin 2)-deficient congenital muscular dystrophy.
9. Malinda KM, Kleinman HK: The laminins. Int J Biochem Cell FEBS Lett 415:33–39, 1997
Biol 28:957–959, 1996 29. Miner JH: Developmental biology of glomerular basement mem-
10. Ryan MC, Christiano AM, Engvall E, Wewer UM, Miner JH, brane components. Curr Opin Nephrol Hypertens 7:13–19, 1998
Sanes JR, Burgeson RE: The functions of laminins: Lessons 30. Durbeej M, Fecker L, Hjalt T, Zhang H-Y, Salmivirta K,
from in vivo studies. Matrix Biol 15:369–381, 1996 Klein G, Timpl R, Sorokin L, Ebendal T, Ekblom P, Ekblom
11. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin M: Expression of laminin a1, a5 and b2 chains during embryogen-
GR: Laminin: A glycoprotein from basement membranes. J Biol esis of the kidney and vasculature. Matrix Biol 15:397–413, 1996
Chem 254:9933–9937, 1979 31. Tiger C-F, Champliaud M-F, Pedrosa-Domellof F, Thornell
12. Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, L-E, Ekblom P, Gullberg D: Presence of laminin a5 chain and
Kleinman H, Martin GR, Ortonne J-P, Paulsson M, Sanes J, lack of laminin a1 chain during human muscle development and
Timpl R, Tryggvason K, Yamada Y, Yurchenco PD: A new in muscular dystrophies. J Biol Chem 272:28590–28595, 1997
nomenclature for laminins. Matrix Biol 14:209–211, 1994 32. Aberdam D, Aguzzi A, Baudoin C, Galliano MF, Ortonne
13. Beck K, Hunter I, Engel J: Structure and function of laminin: JP, Meneguzzi G: Developmental expression of nicein adhesion
Anatomy of a multidomain glycoprotein. FASEB J 4:148–160, protein (laminin-5) subunits suggests multiple morphogenic roles.
1990 Cell Adhes Commun 2:115–129, 1994
14. Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes 33. Sugiyama S, Utani A, Yamada S, Kozak CA, Yamada Y: Cloning
JR: Distribution and isolation of four laminin variants: Tissue and expression of the mouse laminin gamma 2 (B2t) chain, a
restricted distribution of heterotrimers assembled from five differ- subunit of epithelial cell laminin. Eur J Biochem 228:120–128,
ent subunits. Cell Regul 1:731–740, 1990 1995
15. Rousselle P, Lunstrum GP, Keene DR, Burgeson RE: Kalinin: 34. Mizushima H, Koshikawa N, Moriyama K, Takamura H, Naga-
An epithelium-specific basement membrane adhesion molecule shima Y, Hirahara F, Miyazaki K: Wide distribution of laminin-5
that is a component of anchoring filaments. J Cell Biol 114:567– gamma 2 chain in basement membranes of various human tissues.
576, 1991 Horm Res 50:7–14, 1998
16. Marinkovich MP, Lunstrum GP, Keene DR, Burgeson RE: 35. Aberdam D, Galliano MF, Vailly J, Pulkkinen L, Bonifas J,
The dermal-epidermal junction of human skin contains a novel Christiano AM, Tryggvason K, Uitto J, Epstein EH Jr, Or-
laminin variant. J Cell Biol 119:695–703, 1992 tonne JP, Meneguzzi G: Herlitz’s junctional epidermolysis bul-17. Champliaud MF, Lunstrum GP, Rousselle P, Nishiyama T, losa is linked to mutations in the gene (LAMC2) for the gammaKeene DR, Burgeson RE: Human amnion contains a novel lami-
2 subunit of nicein/kalinin (LAMININ-5). Nat Genet 6:299–304,nin variant, laminin 7, which like laminin 6, covalently associates
1994with laminin 5 to promote stable epithelial-stromal attachment.
36. Pulkkinen L, Christiano AM, Airenne T, Haakana H, Trygg-J Cell Biol 132:1189–1198, 1996
vason K, Uitto J: Mutations in the gamma 2 chain gene (LAMC2)18. Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jen-
of kalinin/laminin 5 in the junctional forms of epidermolysis bul-kins NA, Copeland NG, Sanes JR: The laminin a chains: Expres-
losa. Nat Genet 6:293–298, 1994sion, developmental transitions, and chromosomal locations of
37. Pulkkinen L, Christiano AM, Gerecke D, Wagman DW, Bur-a1-5, identification of heterotrimeric laminins 8-11, and cloning
geson RE, Pittelkow MR, Uitto J: A homozygous nonsenseof a novel a3 isoform. J Cell Biol 137:685–701, 1997
mutation in the b3 gene of laminin 5 (LAMB3) in Herlitz junc-19. Koch M, Olson PF, Albus A, Jin W, Hunter DD, Brunken
tional epidermolysis bullosa. Genomics 24:357–360, 1994WJ, Burgeson RE, Champliaud MF: Characterization and ex-
38. McGrath JA, Kivirikko S, Ciatti S, Moss C, Dunnill GS, Eadypression of the laminin gamma3 chain: A novel, non-basement
RA, Rodeck CH, Christiano AM, Uitto J: A homozygous non-membrane-associated, laminin chain. J Cell Biol 145:605–618,
sense mutation in the alpha 3 chain gene of laminin 5 (LAMA3)1999
in Herlitz junctional epidermolysis bullosa: Prenatal exclusion in20. Lindblom A, Marsh T, Fauser C, Engel J, Paulsson M: Charac-
a fetus at risk. Genomics 29:282–284, 1995terization of native laminin from bovine kidney and comparison
39. Kuster JE, Guarnieri MH, Ault JG, Flaherty L, Swiatek PJ:with other laminin variants. Eur J Biochem 219:383–392, 1994
IAP insertion in the murine LamB3 gene results in junctional21. Sorokin LM, Conzelmann S, Ekblom P, Battaglia C, Aumail-
epidermolysis bullosa. Mamm Genome 8:673–681, 1997ley M, Timpl R: Monoclonal antibodies against laminin A chain
40. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanesfragment E3 and their effects on binding to cells and proteoglycan
JR, Merlie JP: The renal glomerulus of mice lacking s-laminin/and on kidney development. Exp Cell Res 201:137–144, 1992
laminin b2: Nephrosis despite molecular compensation by laminin22. Sorokin LM, Pausch F, Durbeej M, Ekblom P: Differential ex-
b1. Nat Genet 10:400–406, 1995pression of five laminin a(1-5) chains in developing and adult
41. Ekblom M, Klein G, Mugrauer G, Fecker L, Deutzmann R,mouse kidney. Dev Dyn 210:446–462, 1997
Timpl R, Ekblom P: Transient and locally restricted expression23. Klein G, Langegger M, Timpl R, Ekblom P: Role of laminin A
of laminin A chain mRNA by developing epithelial cells duringchain in the development of epithelial cell polarity. Cell 55:331–
kidney organogenesis. Cell 60:337–346, 1990341, 1988
42. Miner JH, Cunningham J, Sanes JR: Roles for laminin in em-24. Sanes JR, Engvall E, Butkowski R, Hunter DD: Molecular
bryogenesis: Exencephaly, syndactyly, and placentopathy in miceheterogeneity of basal laminae: Isoforms of laminin and collagen
lacking the laminin a5 chain. J Cell Biol 143:1713–1723, 1998IV at the neuromuscular junction and elsewhere. J Cell Biol
43. Iivanainen A, Morita T, Tryggvason K: Molecular cloning and111:1685–1699, 1990
tissue-specific expression of a novel murine laminin gamma 325. Miner JH, Sanes JR: Collagen IV a3, a4, and a5 chains in rodent
chain. J Biol Chem 274:14107–14111, 1999basal laminae: Sequence, distribution, association with laminins,
44. Hudson BG, Wieslander J, Wisdom BJ Jr, Noelken ME: Biol-and developmental switches. J Cell Biol 127:879–891, 1994
ogy of disease: Goodpasture syndrome: Molecular architecture26. Xu H, Wu X-R, Wewer UM, Engvall E: Murine muscular dys-
and function of basement membrane antigen. Lab Invest 61:256–trophy caused by a mutation in the laminin a2 (Lama2) gene.
269, 1989Nat Genet 8:297–302, 1994
27. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tes- 45. Hudson BG, Reeders ST, Tryggvason K: Type IV collagen:
Miner: Renal basement membrane components 2023
Structure, gene organization, and role in human diseases. J Biol CH, Barrientos A, Monnens LAH, van Oost BA, Brunner
HG, Reeders ST, Smeets HJM: Mutations in the type IV collagenChem 268:26033–26036, 1993
46. Kuhn K: Basement membrane (type IV) collagen. Matrix Biol a3 (COL4A3) gene in autosomal recessive Alport syndrome.
Hum Mol Genet 3:1269–1273, 199414:439–445, 1994
47. Pihlajaniemi T: Molecular properties of the glomerular basement 65. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler
M-C, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH,membrane. Contrib Nephrol 117:46–79, 1996
48. Wisdom BJ Jr, Gunwar S, Hudson MD, Noelken ME, Hudson Smeets HJ, Reeders ST: Identification of mutations in the a3(IV)
and a4(IV) collagen genes in autosomal recessive Alport syn-BG: Type IV collagen of Engelbreth-Holm-Swarm tumor matrix:
Identification of constituent chains. Connect Tissue Res 27:225– drome. Nat Genet 8:77–82, 1994
66. Zheng K, Thorner PS, Marrano P, Baumal R, McInnes RR:234, 1992
49. Kleppel MM, Santi PA, Cameron JD, Wieslander J, Michael Canine X chromosome-linked hereditary nephritis: A genetic
model for human X-linked hereditary nephritis resulting from aAF: Human tissue distribution of novel basement membrane col-
lagen. Am J Pathol 134:813–825, 1989 single base mutation in the gene encoding the a5 chain of collagen
type IV. Proc Natl Acad Sci USA 91:3989–3993, 199450. Hostikka SL, Eddy RL, Byers MG, Hoyhtya M, Shows TB,
Tryggvason K: Identification of a distinct type IV collagen a 67. Miner JH, Sanes JR: Molecular and functional defects in kidneys
of mice lacking collagen a3(IV): Implications for Alport syn-chain with restricted kidney distribution and assignment of its
gene to the locus of X chromosome-linked Alport syndrome. drome. J Cell Biol 135:1403–1413, 1996
68. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Say-Proc Natl Acad Sci USA 87:1606–1610, 1990
51. Kleppel MM, Fan WW, Cheong HI, Kashtan CE, Michael ers R, Hunter WJ, Samuelson GC: Collagen COL4A3 knockout:
A mouse model for autosomal Alport syndrome. Genes DevAF: Immunochemical studies of the Alport antigen. Kidney Int
41:1629–1637, 1992 10:2981–2992, 1996
69. Lemmink HH, Nillesen WN, Mochizuki T, Schroder CH, Brun-52. Lohi J, Korhonen M, Leivo I, Kangas L, Tani T, Kalluri R,
Miner JH, Lehto V-P, Virtanen I: Expression of type IV collagen ner HG, van Oost BA, Monnens LAH, Smeets HJM: Benign
familial hematuria due to mutation of the type IV collagen a4a1(IV)-a6(IV) polypeptides in normal and developing human
kidney and in renal cell carcinomas and oncocytomas. Int J Cancer gene. J Clin Invest 98:1114–1118, 1996
70. Jefferson JA, Lemmink HH, Hughes AE, Hill CM, Smeets72:43–49, 1997
53. Kleppel MM, Fan WW, Cheong HI, Michael AF: Evidence for HJ, Doherty CC, Maxwell AP: Autosomal dominant Alport
syndrome linked to the type IV collagen alpha 3 and alpha 4 genesseparate networks of classical and novel basement membrane
collagen: Characterization of a3(IV)-Alport antigen heterodimer. (COL4A3 and COL4A4). Nephrol Dial Transplant 12:1595–1599,
1997J Biol Chem 267:4137–4142, 1992
54. Kahsai TZ, Enders GC, Gunwar S, Brunmark C, Wieslander 71. Kashtan CE, Kleppel MM, Butkowski RJ, Michael AF, Fish
AJ: Alport syndrome, basement membranes and collagen. PediatrJ, Kalluri R, Zhou J, Noelken ME, Hudson BG: Seminiferous
tubule basement membrane: Composition and organization of Nephrol 4:523–532, 1990
72. Thorner PS, Zheng K, Kalluri R, Jacobs R, Hudson BG:type IV collagen chains, and the linkage of a3(IV) and a5(IV)
chains. J Biol Chem 272:17023–17032, 1997 Coordinate gene expression of the a3, a4, and a5 chains of colla-
gen type IV: Evidence from a canine model of X-linked nephritis55. Gunwar S, Ballester F, Noelken ME, Sado Y, Ninomiya Y,
Hudson BG: Glomerular basement membrane. Identification of a with a COL4A5 gene mutation. J Biol Chem 271:13821–13828,
1996novel disulfide-cross-linked network of alpha3, alpha4, and alpha5
chains of type IV collagen and its implications for the pathogenesis 73. Nakanishi K, Yoshikawa N, Iijima K, Nakamura H: Expression
of type IV collagen a3 and a4 chain mRNA in X-linked Alportof Alport syndrome. J Biol Chem 273:8767–8775, 1998
56. Desjardins M, Gros F, Wieslander J, Gubler M-C, Bendayan syndrome. J Am Soc Nephrol 7:938–945, 1996
74. Kashtan CE, Kim Y: Distribution of the a1 and a2 chains ofM: Heterogeneous distribution of monomeric elements from the
globular domain (NC1) of type IV collagen in renal basement collagen IV and of collagens V and VI in Alport syndrome. Kidney
Int 42:115–126, 1992membranes as revealed by high resolution quantitative immuno-
cytochemistry. Lab Invest 63:637–646, 1990 75. Nakanishi K, Yoshikawa N, Iijima K, Kitagawa K, Nakamura
H, Ito H, Yoshioka K, Kagawa M, Sado Y: Immunohistochemi-57. Butkowski RJ, Wieslander J, Kleppel M, Michael AF, Fish
AJ: Basement membrane collagen in the kidney: Regional local- cal study of a1-5 chains of type IV collagen in hereditary nephritis.
Kidney Int 46:1413–1421, 1994ization of novel chains related to collagen IV. Kidney Int 35:1195–
1202, 1989 76. Gubler M-C, Knebelmann B, Beziau A, Broyer M, Pirson Y,
Haddoum F, Kleppel MM, Antignac C: Autosomal recessive58. Ninomiya Y, Kagawa M, Iyama K, Naito I, Kishiro Y, Seyer
JM, Sugimoto M, Oohashi T, Sado Y: Differential expression of Alport syndrome: Immunohistochemical study of type IV colla-
gen chain distribution. Kidney Int 47:1142–1147, 1995two basement membrane collagen genes, COL4A6 and COL4A5,
demonstrated by immunofluorescence staining using peptide-spe- 77. Kalluri R, Shield CF III, Todd P, Hudson BG, Neilson EG:
Isoform switching of type IV collagen is developmentally arrestedcific monoclonal antibodies. J Cell Biol 130:1219–1229, 1995
59. Peissel B, Gene L, Kalluri R, Kashtan C, Rennke HG, Gallo in X-linked Alport syndrome leading to increased susceptibility
of renal basement membranes to endoproteolysis. J Clin InvestGR, Yoshioka K, Sun MJ, Hudson BG, Neilson EG, Zhou
J: Comparative distribution of the a1(IV), a5(IV), and a6(IV) 99:2470–2478, 1997
78. Butkowski RJ, Langveld JPM, Wieslander J, Hamilton J,collagen chains in normal human adult and fetal tissues and in
kidneys from X-linked Alport syndrome patients. J Clin Invest Hudson BG: Localization of the Goodpasture epitope to a novel
chain of basement membrane collagen. J Biol Chem 262:7874–96:1948–1957, 1995
60. Tryggvason K, Zhou J, Hostikka SL, Shows TB: Molecular 7877, 1987
79. Saus J, Wieslander J, Langeveld JPM, Quinones S, Hudsongenetics of Alport syndrome. Kidney Int 43:38–44, 1993
61. Antignac C: Molecular genetics of basement membranes: The BG: Identification of the Goodpasture antigen as the a3(IV) chain
of collagen IV. J Biol Chem 263:13374–13380, 1988paradigm of Alport syndrome. Kidney Int 47(Suppl 49):S29–S33,
1995 80. Kalluri R, Gunwar S, Reeders ST, Morrison KC, Mariyama M,
Ebner KE, Noelken ME, Hudson BG: Goodpasture syndrome:62. Lemmink HH, Schroder CH, Monnens LA, Smeets HJ: The
clinical spectrum of type IV collagen mutations. Hum Mutat 9: Localization of the epitope for the autoantibodies to the carboxyl-
terminal region of the a3(IV) chain of basement membrane colla-77–499, 1997
63. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, gen. J Biol Chem 266:24018–24024, 1991
81. Turner N, Mason PJ, Brown R, Fox M, Povey S, Rees A,Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggva-
son K: Identification of mutations in the COL4A5 collagen gene Pusey CD: Molecular cloning of the human Goodpasture antigen
demonstrates it to be the a3 chain of type IV collagen. J Clinin Alport syndrome. Science 248:1224–1227, 1990
64. Lemmink HH, Mochizuki T, van den Heuvel PWJ, Schroder Invest 89:592–601, 1992
Miner: Renal basement membrane components2024
82. Kalluri R, Sun MJ, Hudson BG, Neilson EG: The Goodpasture expression of agrin in renal basement membranes as revealed by
domain-specific antibodies. J Biol Chem 273:17832–17838, 1998autoantigen: Structural delineation of two immunologically privi-
leged epitopes on a3(IV) chain of type IV collagen. J Biol Chem 101. Gautam M, Noakes PG, Moscoso L, Rupp F, Scheller RH,
Merlie JP, Sanes JR: Defective neuromuscular synaptogenesis271:9062–9068, 1996
83. Hudson BG, Kalluri R, Gunwar S, Weber M, Ballester F, in agrin-deficient mutant mice. Cell 85:525–535, 1996
102. McCarthy KJ, Couchman JR: Basement membrane chondroitinHudson JK, Noelken ME, Sarras M, Richardson WR, Saus
J, Abrahamson DR, Glick AD, Haralson MA, Helderman JH, sulfate proteoglycans: Localization in adult rat tissues. J Histo-
chem Cytochem 38:1479–1486, 1990Stone WJ, Jacobson HR: The pathogenesis of Alport syndrome
involves type IV collagen molecules containing the a3(IV) chain: 103. Wu R-R, Couchman JR: cDNA cloning of the basement mem-
brane chondroitin sulfate proteoglycan core protein, bamacan: AEvidence from anti-GBM nephritis after renal transplantation.
Kidney Int 42:179–187, 1992 five domain structure including coiled-coil motifs. J Cell Biol
136:433–444, 199784. Kalluri R, Weber M, Netzer KO, Sun MJ, Neilson EG, Hud-
son BG: COL4A5 gene deletion and production of post-trans- 104. McCarthy KJ, Bynum K, St. John PL, Abrahamson DR, Couch-
man JR: Basement membrane proteoglycans in glomerular mor-plant anti-alpha 3(IV) collagen alloantibodies in Alport syn-
drome. Kidney Int 45:721–726, 1994 phogenesis: Chondroitin sulfate proteoglycan is temporally and
spatially restricted during development. J Histochem Cytochem85. Kalluri R, van den Heuvel LP, Smeets HJM, Schroder CH,
Lemmink HH, Boutaud A, Neilson EG, Hudson BG: A 41:401–414, 1993
105. Muragaki Y, Timmons S, Griffith CM, Oh SP, Fadel B, Quert-COL4A3 gene mutation and post-transplant anti-a3(IV) collagen
alloantibodies in Alport syndrome. Kidney Int 47:1199–1204, 1995 ermous T, Olsen BR: Mouse Col18a1 is expressed in a tissue-
specific manner as three alternative variants and is localized in86. Dehan P, van den Heuvel LPWJ, Smeets HJM, Tryggvason K,
Foidart J-M: Identification of post-transplant anti-a5(IV) colla- basement membrane zones. Proc Natl Acad Sci USA 92:8763–
8767, 1995gen alloantibodies in X-linked Alport syndrome. Nephrol Dial
Transplant 11:1983–1988, 1996 106. Halfter W, Dong S, Schurer B, Cole GJ: Collagen XVIII is a
basement membrane heparan sulfate proteoglycan. J Biol Chem87. Brainwood D, Kashtan C, Gubler MC, Turner AN: Targets
of alloantibodies in Alport anti-glomerular basement membrane 273:25404–25412, 1998
107. O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS,disease after renal transplantation. Kidney Int 53:762–766, 1998
88. Chung AE, Durkin ME: Entactin: Structure and function. Am Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: An
endogenous inhibitor of angiogenesis and tumor growth. CellJ Respir Cell Mol Biol 3:275–282, 1990
89. Mayer U, Nischt R, Poschl E, Mann K, Fukuda K, Gerl M, 88:277–285, 1997
108. Saxen L: Organogenesis of the Kidney. Cambridge, CambridgeYamada Y, Timpl R: A single EGF-like motif of laminin is respon-
sible for high affinity nidogen binding. EMBO J 12:1879–1885, University Press, 1987
109. Sorokin L, Ekblom P: Development of tubular and glomerular1993
90. Mayer U, Poschl E, Gerecke DR, Wagman DW, Burgeson cells of the kidney. Kidney Int 41:657–664, 1992
110. Harvey SJ, Zheng K, Sado Y, Naito I, Ninomiya Y, Jacobs RM,RE, Timpl R: Low nidogen affinity of laminin-5 can be attributed
to two serine residues in EGF-like motif gamma 2III4. FEBS Lett Hudson BG, Thorner PS: Role of distinct type IV collagen
networks in glomerular development and function. Kidney Int365:129–132, 1995
91. Kimura N, Toyoshima T, Kojima T, Shimane M: Entactin-2: A 54:1857–1866, 1998
111. Kleppel MM, Michael AF: Expression of novel basement mem-new member of basement membrane protein with high homology
to entactin/nidogen. Exp Cell Res 241:36–45, 1998 brane components in the developing human kidney and eye. Am
J Anat 187:165–174, 199092. Kohfeldt E, Sasaki T, Gohring W, Timpl R: Nidogen-2: A new
basement membrane protein with diverse binding properties. J Mol 112. Kuroda N, Yoshikawa N, Nakanishi K, Iijima K, Hanioka K,
Hayashi Y, Imai Y, Sado Y, Nakayama M, Itoh H: ExpressionBiol 282:99–109, 1998
93. Timpl R: Proteoglycans of basement membranes. Experientia 49: of type IV collagen in the developing human kidney. Pediatr
Nephrol 12:554–558, 1998417–428, 1993
94. Couchman JR, Kapoor R, Sthanam M, Wu R-R: Perlecan and 113. Noakes PG, Gautam M, Mudd J, Sanes JR, Merlie JP: Aberrant
differentiation of neuromuscular junctions in mice lacking s-lami-basement membrane-chondroitin sulfate proteoglycan (Bamacan)
are two basement membrane chondroitin/dermatan sulfate pro- nin/laminin b2. Nature 374:258–262, 1995
114. Olgemoller B, Schleicher E: Alterations of glomerular matrixteoglycans in the Engelbreth-Holm-Swarm tumor matrix. J Biol
Chem 271:9595–9602, 1996 proteins in the pathogenesis of diabetic nephropathy. Clin Invest
71:S13–S19, 199395. Farquhar MG: The glomerular basement membrane: A selective
macromolecular filter, in Cell Biology of Extracellular Matrix, 115. Ziyadeh FN: The extracellular matrix in diabetic nephropathy.
Am J Kidney Dis 22:736–744, 1993edited by Hay ED, New York, Plenum Press, 1981, pp 335–378
96. Noonan DM, Fulle A, Valente P, Cai S, Horigan E, Sasaki 116. Adler S: Structure-function relationships associated with extra-
cellular matrix alterations in diabetic glomerulopathy. (editorial)M, Yamada Y, Hassell JR: The complete sequence of perlecan,
a basement membrane heparan sulfate proteoglycan, reveals ex- J Am Soc Nephrol 5:1165–1172, 1994
117. Kim Y, Butkowski R, Burke B, Kleppel MM, Crosson J, Katztensive similarity with laminin A chain, low density lipoprotein-
receptor, and the neural cell adhesion molecule. J Biol Chem A, Michael AF: Differential expression of basement membrane
collagen in membranous nephropathy. Am J Pathol 139:1381–266:22939–22947, 1991
97. Tsen G, Lalfter W, Kroger S, Cole GJ: Agrin is a heparan 1388, 1991
118. Buyukbabani N, Droz D: Distribution of the extracellular matrixsulfate proteoglycan. J Biol Chem 270:3392–3399, 1995
98. Groffen AJ, Ruegg MA, Dijkman H, van de Velden TJ, components in human glomerular lesions. J Pathol 172:199–207,
1994Buskens CA, van den Born J, Assmann KJ, Monnens LA,
Veerkamp JH, van den Heuvel LP: Agrin is a major heparan 119. Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es
LA, Bruijn JA: Progression of chronic renal disease in humanssulfate proteoglycan in the human glomerular basement mem-
brane. J Histochem Cytochem 46:19–27, 1998 is associated with the deposition of basement membrane compo-
nents and decorin in the interstitial extracellular matrix. Clin99. Groffen AJ, Buskens CA, van Kuppevelt TH, Veerkamp JH,
Monnens LA, van den Heuvel LP: Primary structure and high Nephrol 44:211–219, 1995
120. Abrass CK, Berfield AK, Stehman-Breen C, Alpers CE, Davisexpression of human agrin in basement membranes of adult lung
and kidney. Eur J Biochem 254:123–128, 1998 CL: Unique changes in interstitial extracellular matrix composi-
tion are associated with rejection and cyclosporine toxicity in100. Raats CJ, Bakker MA, Hoch W, Tamboer WP, Groffen AJ,
van den Heuvel LP, Berden JH, van den Born J: Differential human renal allograft biopsies. Am J Kidney Dis 33:11–20, 1999
